Maven Securities LTD Madrigal Pharmaceuticals, Inc. Transaction History

Maven Securities LTD

  • $585 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
BUY
$146.04 - $225.78 $481,639 - $744,622
3,298 New
3,298 $481,000
Q3 2021

Nov 15, 2021
SELL
$78.35 - $105.02 $3.92 Million - $5.25 Million
-50,000 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$97.2 - $137.59 $4.86 Million - $6.88 Million
50,000 New
50,000 $4.91 Million

Others Institutions Holding MDGL

# of Institutions
297
Shares Held
21.9M
Call Options Held
757K
Put Options Held
370K
View Full List

About MADRIGAL PHARMACEUTICALS, INC.

MDGL Quotes by TradingView
  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $3.72B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Maven Securities LTD Portfolio

Follow Maven Securities LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email